-
Posted by
Two Blokes April 22, 2025 -
Filed in
Stock
-
17 views
Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug developer Fujifilm Diosynth to expand its U.S. manufacturing capacity.